As the demand for weight loss injectables soars, so too does the market for off-brand alternatives, some of which may not be ...

A turbulent series of events around the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around ...

Viking Therapeutics stock ramped higher Thursday after the company outlined its weight-loss quad — a blow to Eli Lilly's ...

The government will not be paying the pharmaceutical firm Lilly £280 million to run a widely reported five-year trial into the impact of weight loss injections, despite confusion online.

Lilly will launch its Mounjaro obesity drug in Denmark next week, the U.S. drugmaker said on Thursday, bringing competition ...

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...

Pharmacies currently making copycat versions of Eli Lilly’s tirzepatide face heightened exposure to state enforcement actions ...

Last spring, Eli Lilly reported its drugs Humalog and insulin lispro ... He said the weekly injections and easy-to-use ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

The sellers of these online products acknowledge that many of their drugs are for ‘research purposes only’ or ‘not for human ...